Table 1.
Characteristics of the NSCLC primary tumours tested
| Tumour # | Gender, age at excision | Site | Clinical diagnosis of specimen | AJCC/UICC stage group | Medications | Genetic analysis |
|---|---|---|---|---|---|---|
| 1 | F, 79 | Lung | Squamous cell carcinoma of the lung | IA | SNPs: rs2075607 (LKB1), rs1042522 (TP53) | |
| 2 | M, 57 | Lung | Adenocarcinoma of the lung | IIB | Combivent | nd |
| Lovenox | ||||||
| Advair | ||||||
| 3 | M, 61 | Abdominal wall | Metastatic neoplasm of the abdominal wall | IV | Carboplatin | Highly aberrant copy number variations across genome |
| Paclitaxel | Point mutations: KRas G12D, TP53 V157F | |||||
| Alimta | SNPs: rs2075607 (LKB1) | |||||
| Tarceva | ||||||
| Gemcitabine |